1. Home
  2. CHH vs BLCO Comparison

CHH vs BLCO Comparison

Compare CHH & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHH
  • BLCO
  • Stock Information
  • Founded
  • CHH 1939
  • BLCO 1853
  • Country
  • CHH United States
  • BLCO Canada
  • Employees
  • CHH N/A
  • BLCO N/A
  • Industry
  • CHH Hotels/Resorts
  • BLCO Ophthalmic Goods
  • Sector
  • CHH Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • CHH Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • CHH 6.8B
  • BLCO 5.6B
  • IPO Year
  • CHH 1997
  • BLCO 2022
  • Fundamental
  • Price
  • CHH $144.99
  • BLCO $16.10
  • Analyst Decision
  • CHH Hold
  • BLCO Buy
  • Analyst Count
  • CHH 13
  • BLCO 11
  • Target Price
  • CHH $140.46
  • BLCO $20.00
  • AVG Volume (30 Days)
  • CHH 467.9K
  • BLCO 634.1K
  • Earning Date
  • CHH 02-20-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • CHH 0.79%
  • BLCO N/A
  • EPS Growth
  • CHH 22.29
  • BLCO N/A
  • EPS
  • CHH 6.20
  • BLCO N/A
  • Revenue
  • CHH $791,189,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • CHH $107.66
  • BLCO $7.05
  • Revenue Next Year
  • CHH $3.96
  • BLCO $5.83
  • P/E Ratio
  • CHH $23.41
  • BLCO N/A
  • Revenue Growth
  • CHH 4.10
  • BLCO 15.56
  • 52 Week Low
  • CHH $109.22
  • BLCO $13.16
  • 52 Week High
  • CHH $157.86
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • CHH 46.49
  • BLCO 44.71
  • Support Level
  • CHH $140.38
  • BLCO $15.54
  • Resistance Level
  • CHH $146.12
  • BLCO $16.10
  • Average True Range (ATR)
  • CHH 5.06
  • BLCO 0.41
  • MACD
  • CHH -0.70
  • BLCO 0.06
  • Stochastic Oscillator
  • CHH 41.29
  • BLCO 54.13

About CHH Choice Hotels International Inc.

As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: